<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dashti P</submitter><funding>NIAMS NIH HHS</funding><pagination>116866</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10962865</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>176</volume><pubmed_abstract>Osteoblast differentiation is epigenetically suppressed by the H3K27 methyltransferase EZH2, and induced by the morphogen BMP2 and transcription factor RUNX2. These factors also regulate distinct G protein coupled receptors (GPRCs; e.g., PTH1R, GPR30/GPER1). Because GPRCs transduce many physiological stimuli, we examined whether BMP2 or EZH2 inhibition (i.e., GSK126) regulates other GPRC genes in osteoblasts. RNA-seq screening of >400 mouse GPRC-related genes showed that many GPRCs are downregulated during osteogenic differentiation. The orphan receptor GPRC5C, along with a small subset of other GPRCs, is induced by BMP2 or GSK126 during Vitamin C dependent osteoblast differentiation, but not by all-trans retinoic acid. ChIP-seq analysis revealed that GSK126 reduces H3K27me3 levels at the </pubmed_abstract><journal>Bone</journal><pubmed_title>G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.</pubmed_title><pmcid>PMC10962865</pmcid><funding_grant_id>R01 AR049069</funding_grant_id><pubmed_authors>van der Eerden BJ</pubmed_authors><pubmed_authors>Thaler R</pubmed_authors><pubmed_authors>Hawse JR</pubmed_authors><pubmed_authors>Galvan ML</pubmed_authors><pubmed_authors>van Wijnen AJ</pubmed_authors><pubmed_authors>Dudakovic A</pubmed_authors><pubmed_authors>Dashti P</pubmed_authors></additional><is_claimable>false</is_claimable><name>G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.</name><description>Osteoblast differentiation is epigenetically suppressed by the H3K27 methyltransferase EZH2, and induced by the morphogen BMP2 and transcription factor RUNX2. These factors also regulate distinct G protein coupled receptors (GPRCs; e.g., PTH1R, GPR30/GPER1). Because GPRCs transduce many physiological stimuli, we examined whether BMP2 or EZH2 inhibition (i.e., GSK126) regulates other GPRC genes in osteoblasts. RNA-seq screening of >400 mouse GPRC-related genes showed that many GPRCs are downregulated during osteogenic differentiation. The orphan receptor GPRC5C, along with a small subset of other GPRCs, is induced by BMP2 or GSK126 during Vitamin C dependent osteoblast differentiation, but not by all-trans retinoic acid. ChIP-seq analysis revealed that GSK126 reduces H3K27me3 levels at the </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-06-03T07:21:09.661Z</modification><creation>2025-04-06T09:33:48.093Z</creation></dates><accession>S-EPMC10962865</accession><cross_references><pubmed>37558192</pubmed><doi>10.1016/j.bone.2023.116866</doi></cross_references></HashMap>